Table 1

Demographic and clinical details of the participants (n=354)

CharacteristicGlaucoma group
(n=270)
Control group
(n=84)
P value
Age (years), mean (SD)41.93 (12.81)38.89 (14.54)0.067*
Female, no (%)125 (46)49 (58)0.054†
Education level (≥high school), no (%)178 (66)75 (89)<0.001†
Employed, no (%)130 (48)55 (65)0.005†
Urban, no (%)178 (66)68 (81)0.009†
LogMAR PVA in the better eye
 Mean (SD)0.27 (0.25)0.10 (0.12)<0.001*
 Median (IQR)0.20 (0.10–0.40)0.10 (0.00–0.20)
MD in the better eye (dB)
 Mean (SD)−11.30 (9.51)−1.71 (1.30)
 Median (IQR)−7.93 (−16.84 to −3.47)−1.53 (−2.43 to −0.98)<0.001‡
PSD in the better eye (dB)
 Mean (SD)5.70 (3.77)1.49 (0.68)
 Median (IQR)4.83 (2.26–8.56)1.50 (1.29–1.75)<0.001‡
VFI in the better eye
 Mean (SD)0.71 (0.30)0.99 (0.01)
 Median (IQR)0.84 (0.54–0.97)0.99 (0.99–1.00)<0.001‡
Diagnosed for more than 2 years, no (%)163 (60)NA
History of glaucoma surgery, no (%)146 (54)NA
  • *Two-sample t test.

  • †χ2 test.

  • ‡Wilcoxon rank sum test.

  • LogMAR, logarithm of the minimum angle of resolution; MD, mean deviation; NA, not available; PSD, pattern SD; PVA, presenting visual acuity; VFI, Visual Field Index.